Equities

Lushang Freda Pharmaceutical Co Ltd

600223:SHH

Lushang Freda Pharmaceutical Co Ltd

Actions
Real EstateReal Estate Investment and Services
  • Price (CNY)6.19
  • Today's Change0.03 / 0.49%
  • Shares traded6.48m
  • 1 Year change-31.22%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,6871,6382,247
Total Receivables, Net3,6712,2891,904
Total Inventory52546,04748,204
Prepaid expenses552,8313,303
Other current assets, total462,8233,012
Total current assets5,98455,62958,670
Property, plant & equipment, net1,2151,4021,350
Goodwill, net154156160
Intangibles, net182225223
Long term investments238934883
Note receivable - long term------
Other long term assets------
Total assets7,81858,47461,415
LIABILITIES
Accounts payable4487,5187,468
Accrued expenses1471,7411,678
Notes payable/short-term debt84318,79416,686
Current portion long-term debt/capital leases7963,2002,304
Other current liabilities, total16819,35322,956
Total current liabilities2,40250,60651,093
Total long term debt6782,2373,759
Total debt2,31724,23022,749
Deferred income tax2.738.555.24
Minority interest6651,8501,773
Other liabilities, total555659
Total liabilities3,80354,75756,688
SHAREHOLDERS EQUITY
Common stock1,0171,0171,009
Additional paid-in capital613618616
Retained earnings (accumulated deficit)2,3862,0822,202
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total----900
Total equity4,0153,7174,727
Total liabilities & shareholders' equity7,81858,47461,415
Total common shares outstanding1,0171,0171,009
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.